PEG-rhG-CSF in Patients With Breast Cancer Receiving Chemotherapy

Saftey and Efficacy of Pegfilgrastim in Preventing Chrmotherapy-induced Neutropenia

NCT01918241 ·Status: UNKNOWN ·Phase: PHASE2

The Efficacy and Safety of PEG-rhG-CSF in Neutropenia After Chemotherapy

NCT02905916 ·Status: UNKNOWN ·Phase: PHASE4

Efficacy and Safety of 4.5mg PEG-rhG-CSF Per Cycle in Preventing Neutropenia After Intensive Chemotherapy for Breast Cancer

NCT04009941 ·Status: COMPLETED ·Phase: PHASE4

A Study Comparing Pegylated rhG-CSF and rhG-CSF as Support to Breast Cancer Patients Receiving Chemotherapy

NCT01611051 ·Status: COMPLETED ·Phase: PHASE3

Trial to Compare the Efficacy and Safety Of MW05 and PEG-rhG-CSF

NCT04554056 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Real World Study of PEG-rhG-CSF in Prevention of Chemotherapy-induced Neutropenia

NCT03846414 ·Status: UNKNOWN

Efficacy and Safety of PEG-rhG-CSF in the Prevention of Neutropenia After Chemo in Pts With Gynecological Malignancies

NCT04773327 ·Status: UNKNOWN ·Phase: NA

Study Evaluating PEG-G-CSF Injectionin Preventing Neutropenia After Chemotherapy

NCT06711523 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Safety and Efficacy of YPEG-rhG-CSF in Cancer Patients Receiving Chemotherapy

NCT02005458 ·Status: COMPLETED ·Phase: PHASE2

A Phase II Study Comparing Pegylated rhG-CSF（HHPG-19K） and rhG-CSF in Breast Cancer Patients Receiving Chemotherapy

NCT02119715 ·Status: COMPLETED ·Phase: PHASE2

Recombinant Human Serum Albumin/Granulocyte Colony Stimulating Factor Fusion Protein for Breast Cancer Patients

NCT03251768 ·Status: COMPLETED ·Phase: PHASE2

A Real World Study Evaluating the Clinical Application of PEG-rhG-CSF During Chemotherapy in Patients With Solid Tumors

NCT03798665 ·Status: UNKNOWN

Treatment for Elderly Patients With High Risk Breast Cancer

NCT00117910 ·Status: COMPLETED ·Phase: PHASE3

Phase 3 Study to Evaluate the Safety and Efficacy of YPEG-rhG-CSF in Malignancies Receiving Chemotherapy

NCT04466137 ·Status: COMPLETED ·Phase: PHASE3

Same Day Dosing of Pegfilgrastim in Breast Cancer Patients Undergoing Chemotherapy (TAC)

NCT00115414 ·Status: COMPLETED ·Phase: PHASE2

Efficacy, Safety and Cost-effectiveness of PEG-rhG-CSF for Primary vs Secondary Prophylaxis

NCT03701841 ·Status: UNKNOWN

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of YPEG-Filgrastim in Chemotherapy Patients

NCT01238562 ·Status: COMPLETED ·Phase: PHASE1

Intermittent G-CSF in Patients With Breast Cancer Receiving Adjuvant Docetaxel, Doxorubicin, and Cyclophosphamide (TAC)

NCT02685111 ·Status: TERMINATED ·Phase: PHASE2

PEG-rhG-CSF in Patients With Non-Hodgkin Lymphoma Receiving Chemotherapy to Prevent Neutropenia

NCT02996617 ·Status: UNKNOWN ·Phase: PHASE4

Nanogen Pegfilgrastim (Pegcyte) PK/PD Clinical Study in Breast Cancer Patients

NCT03376503 ·Status: COMPLETED ·Phase: PHASE1

Phase II Study of DA-3031(PEG-G-CSF) in Chemotherapy-induced Neutropenia

NCT01923545 ·Status: COMPLETED ·Phase: PHASE2

Telpegfilgrastim Injection to Reduce the Risk of Neutropenia in Patients With Solid Tumor

NCT07096479 ·Status: RECRUITING

FIRST - Study of Pegfilgrastim Administered in the First and Subsequent Cycles of Myelosuppressive Chemotherapy

NCT00125723 ·Status: COMPLETED ·Phase: PHASE4

Study to Assess the Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of GW003 in Patients With Breast Cancer

NCT02725606 ·Status: UNKNOWN ·Phase: PHASE1

Compare the Efficacy and Safety of QL0605 Injections at Different Timepoints

NCT06616571 ·Status: RECRUITING ·Phase: PHASE4